Skip to main content
Erschienen in: Journal of Hematopathology 3/2013

01.09.2013 | Case Report

Precursor T acute lymphoblastic leukemia from myelodysplastic syndrome in Fanconi anemia

verfasst von: Julie C. Dueber, Claudio Mosse, Catherine E. Alford, David Head, Megan Kressin

Erschienen in: Journal of Hematopathology | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

Fanconi anemia is a rare autosomal recessive disease which is associated with an increased risk of malignancy. Acute myeloid leukemia and myelodysplastic syndrome are the most common malignancies. This case report is on an infant who was diagnosed with Fanconi anemia and developed myelodysplastic syndrome in his first year of life which later likely transformed into T acute lymphoblastic leukemia. These findings were demonstrated by FISH. The case highlights a rare lymphoid neoplasm in an FA patient and also the increased incidence of T lineage neoplasms when MDS transforms into a lymphoid leukemia.
Literatur
1.
Zurück zum Zitat Kutler DI, Singh B, Satagopan J et al (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101(4):1249–1256PubMedCrossRef Kutler DI, Singh B, Satagopan J et al (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101(4):1249–1256PubMedCrossRef
2.
Zurück zum Zitat Mehta PA, Harris RE, Davies SM et al (2010) Numerical chromosomal changes and risk of development of myelodysplastic syndrome–acute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet 203(2):180–186PubMedCrossRef Mehta PA, Harris RE, Davies SM et al (2010) Numerical chromosomal changes and risk of development of myelodysplastic syndrome–acute myeloid leukemia in patients with Fanconi anemia. Cancer Genet Cytogenet 203(2):180–186PubMedCrossRef
4.
Zurück zum Zitat Disperati P, Ichim CV, Tkachuk D, Chun K, Schuh AC, Wells RA (2006) Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. Leuk Res 30(2):233–239PubMedCrossRef Disperati P, Ichim CV, Tkachuk D, Chun K, Schuh AC, Wells RA (2006) Progression of myelodysplasia to acute lymphoblastic leukaemia: implications for disease biology. Leuk Res 30(2):233–239PubMedCrossRef
5.
Zurück zum Zitat Miura I, Kobayashi Y, Takahashi N, Saitoh K, Miura AB (2000) Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting. Br J Haematol 110(4):876–879PubMedCrossRef Miura I, Kobayashi Y, Takahashi N, Saitoh K, Miura AB (2000) Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting. Br J Haematol 110(4):876–879PubMedCrossRef
6.
Zurück zum Zitat Goldgar DE, Easton DF, Deffenbaugh AM et al (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75(4):535–544PubMedCrossRef Goldgar DE, Easton DF, Deffenbaugh AM et al (2004) Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2. Am J Hum Genet 75(4):535–544PubMedCrossRef
7.
Zurück zum Zitat Alter BP, Rosenberg PS, Brody LC (2007) Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J Med Genet 44(1):1–9PubMedCrossRef Alter BP, Rosenberg PS, Brody LC (2007) Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. J Med Genet 44(1):1–9PubMedCrossRef
8.
Zurück zum Zitat Tezcan I, Tuncer M, Uçkan D et al (1998) Allogeneic bone marrow transplantation in Fanconi anemia from Turkey: a report of four cases. Pediatr Transplant 2(3):236–239PubMed Tezcan I, Tuncer M, Uçkan D et al (1998) Allogeneic bone marrow transplantation in Fanconi anemia from Turkey: a report of four cases. Pediatr Transplant 2(3):236–239PubMed
9.
Zurück zum Zitat Wada E, Murata M, Watanabe S (1989) Acute lymphoblastic leukemia following treatment with human growth hormone in a boy with possible preanemic Fanconi’s anemia. Jpn J Clin Oncol 19(1):36–39PubMed Wada E, Murata M, Watanabe S (1989) Acute lymphoblastic leukemia following treatment with human growth hormone in a boy with possible preanemic Fanconi’s anemia. Jpn J Clin Oncol 19(1):36–39PubMed
10.
Zurück zum Zitat Sugita K, Taki T, Hayashi Y et al (2000) MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia. Genes Chromosome Cancer 27(3):264–269CrossRef Sugita K, Taki T, Hayashi Y et al (2000) MLL-CBP fusion transcript in a therapy-related acute myeloid leukemia with the t(11;16)(q23;p13) which developed in an acute lymphoblastic leukemia patient with Fanconi anemia. Genes Chromosome Cancer 27(3):264–269CrossRef
11.
Zurück zum Zitat Borriello A, Locasciulli A, Bianco AM et al (2007) A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia. Leukemia 21(1):72–78PubMedCrossRef Borriello A, Locasciulli A, Bianco AM et al (2007) A novel Leu153Ser mutation of the Fanconi anemia FANCD2 gene is associated with severe chemotherapy toxicity in a pediatric T-cell acute lymphoblastic leukemia. Leukemia 21(1):72–78PubMedCrossRef
12.
Zurück zum Zitat Yetgin S, Tuncer M, Güler E, Duru F, Ali Kasifolu M (1994) Acute lymphoblastic leukemia in Fanconi’s anemia. Am J Hematol 45(1):94PubMedCrossRef Yetgin S, Tuncer M, Güler E, Duru F, Ali Kasifolu M (1994) Acute lymphoblastic leukemia in Fanconi’s anemia. Am J Hematol 45(1):94PubMedCrossRef
13.
Zurück zum Zitat Goldsby RE, Perkins SL, Virshup DM, Brothman AR, Bruggers CS (1999) Lymphoblastic lymphoma and excessive toxicity from chemotherapy: an unusual presentation for Fanconi anemia. J Pediatr Hematol Oncol 21(3):240–243PubMedCrossRef Goldsby RE, Perkins SL, Virshup DM, Brothman AR, Bruggers CS (1999) Lymphoblastic lymphoma and excessive toxicity from chemotherapy: an unusual presentation for Fanconi anemia. J Pediatr Hematol Oncol 21(3):240–243PubMedCrossRef
14.
Zurück zum Zitat Suzuki D, Kobayashi R, Yasuda K et al (2011) Precursor-T lymphoblastic lymphoma after unrelated bone marrow transplantation in a patient with Fanconi anemia. J Pediatr Hematol Oncol 33(1):22–24PubMedCrossRef Suzuki D, Kobayashi R, Yasuda K et al (2011) Precursor-T lymphoblastic lymphoma after unrelated bone marrow transplantation in a patient with Fanconi anemia. J Pediatr Hematol Oncol 33(1):22–24PubMedCrossRef
Metadaten
Titel
Precursor T acute lymphoblastic leukemia from myelodysplastic syndrome in Fanconi anemia
verfasst von
Julie C. Dueber
Claudio Mosse
Catherine E. Alford
David Head
Megan Kressin
Publikationsdatum
01.09.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Hematopathology / Ausgabe 3/2013
Print ISSN: 1868-9256
Elektronische ISSN: 1865-5785
DOI
https://doi.org/10.1007/s12308-012-0168-2

Weitere Artikel der Ausgabe 3/2013

Journal of Hematopathology 3/2013 Zur Ausgabe

Neu im Fachgebiet Pathologie

Molekularpathologische Untersuchungen im Wandel der Zeit

Open Access Biomarker Leitthema

Um auch an kleinen Gewebeproben zuverlässige und reproduzierbare Ergebnisse zu gewährleisten ist eine strenge Qualitätskontrolle in jedem Schritt des Arbeitsablaufs erforderlich. Eine nicht ordnungsgemäße Prüfung oder Behandlung des …

Vergleichende Pathologie in der onkologischen Forschung

Pathologie Leitthema

Die vergleichende experimentelle Pathologie („comparative experimental pathology“) ist ein Fachbereich an der Schnittstelle von Human- und Veterinärmedizin. Sie widmet sich der vergleichenden Erforschung von Gemeinsamkeiten und Unterschieden von …

Gastrointestinale Stromatumoren

Open Access GIST CME-Artikel

Gastrointestinale Stromatumoren (GIST) stellen seit über 20 Jahren ein Paradigma für die zielgerichtete Therapie mit Tyrosinkinaseinhibitoren dar. Eine elementare Voraussetzung für eine mögliche neoadjuvante oder adjuvante Behandlung bei …

Personalisierte Medizin in der Onkologie

Aufgrund des erheblichen technologischen Fortschritts in der molekularen und genetischen Diagnostik sowie zunehmender Erkenntnisse über die molekulare Pathogenese von Krankheiten hat in den letzten zwei Jahrzehnten ein grundlegender …